Table 1.
Patient characteristics in the whole cohort
| |
Total N = 559 (%) |
|---|---|
| Age, years | 49.5 |
|
ER |
|
| Negative |
204 (36.5) |
| Positive |
345 (61.7) |
| Unknown |
10 (1.8) |
|
Grade |
|
| I |
130 (23.3) |
| II |
204 (36.5) |
| III |
105 (18.8) |
| Unknown |
120 (21.5) |
|
Tumor Size |
|
| T1 |
235 (42.0) |
| T2 |
285 (51.0) |
| T3 |
39 (7.0) |
|
Node |
|
| N0 |
323 (57.8) |
| N1 |
135 (24.2) |
| N2 |
50 (8.9) |
| N3 |
51 (9.1) |
|
Status |
|
| Died |
87 (15.6) |
| Survived |
472 (84.4) |
|
Hormone therapy |
|
| Yes |
476 (85.2) |
| No |
83 (14.8) |
|
Chemotherapy |
|
| Yes |
381 (68.2) |
| No |
149 (26.7) |
| Less than expected cycles | 29 (5.1) |